Dr. Angad Deengar, MD Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-4763 Fax: 860-679-4624 |
Joseph Palmisano, MD Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-2160 Fax: 860-679-1042 |
Dr. Adrian A Salmon, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-3343 Fax: 860-679-4256 |
Raymond J Foley, D.O. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Cardiology, Farmington, CT 06030 Phone: 860-679-3343 Fax: 860-679-4256 |
Dana R Crino, M.D. Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: University Of Connecticut Health Ctr, 263 Farmington Avenue, Farmington, CT 06030 Phone: 860-679-2715 |
Nausherwan K Burki, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-3343 Fax: 860-679-4256 |
Debapriya Datta, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: Division Of Pulmonary &, 263 Farmington Avenue, Farmington, CT 06030 Phone: 860-679-3585 Fax: 860-679-1103 |
Dr. Gracia Mui, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-4888 |
News Archive
Ask anyone who suffers from migraine headaches what they do when they're having an attack, and you're likely to hear "go into a dark room." And although it's long been known that light makes migraines worse, the reason why has been unclear.
Patients at an academic medical center who are cared for by a hospital-based general physician may have a shorter length of hospital stay than those who are not, especially if the patients require close monitoring or complex discharge planning, according to a report in the September 24 issue of Archives of Internal Medicine.
Pharmasset, Inc. announced today that safety and pharmacokinetic data from the PSI-352938 single ascending dose study support progression to a multiple ascending dose trial with PSI-938, which has initiated dosing. PSI-938 is a guanine nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C virus infection.
The very premise of prison invites members of society to think of the people there as walled-off and removed. But more than 95 percent of prisoners will return to the community, often carrying significant health burdens and associated costs with them. In an article in the March issue of the journal Health Affairs, several experts who participated in a scientific workshop convened by the National Research Council and the Institute of Medicine recommend several steps and ideas consistent with health reform to improve care for prisoners while they are incarcerated and after they return to society.
› Verified 7 days ago